Noble Dental Laboratories Ltd - Accounts to registrar (filleted) - small 18.2

Noble Dental Laboratories Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.2.0.360 SC398955 director 1.4.17 31.3.18 31.3.18 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC3989552017-03-31SC3989552018-03-31SC3989552017-04-012018-03-31SC3989552016-03-31SC3989552016-04-012017-03-31SC3989552017-03-31SC398955ns14:PoundSterling2017-04-012018-03-31SC398955ns10:Director12017-04-012018-03-31SC398955ns10:PrivateLimitedCompanyLtd2017-04-012018-03-31SC398955ns10:SmallEntities2017-04-012018-03-31SC398955ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-31SC398955ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-31SC398955ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-31SC398955ns10:FullAccounts2017-04-012018-03-31SC39895512017-04-012018-03-31SC398955ns5:CurrentFinancialInstruments2018-03-31SC398955ns5:CurrentFinancialInstruments2017-03-31SC398955ns5:Non-currentFinancialInstruments2018-03-31SC398955ns5:Non-currentFinancialInstruments2017-03-31SC398955ns5:ShareCapital2018-03-31SC398955ns5:ShareCapital2017-03-31SC398955ns5:RetainedEarningsAccumulatedLosses2018-03-31SC398955ns5:RetainedEarningsAccumulatedLosses2017-03-31SC398955ns5:NetGoodwill2017-04-012018-03-31SC398955ns5:PlantMachinery2017-04-012018-03-31SC398955ns5:NetGoodwill2017-03-31SC398955ns5:NetGoodwill2018-03-31SC398955ns5:NetGoodwill2017-03-31SC398955ns5:PlantMachinery2017-03-31SC398955ns5:PlantMachinery2018-03-31SC398955ns5:PlantMachinery2017-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2017-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2017-04-012018-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2018-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2017-03-31SC398955ns5:LeasedAssetsHeldAsLessee2017-04-012018-03-31SC398955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-31SC398955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-31


REGISTERED NUMBER: SC398955















NOBLE DENTAL LABORATORIES LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2018






NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018




Page

Balance Sheet 1

Notes to the Financial Statements 3


NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

BALANCE SHEET
31 MARCH 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 96,000 112,000
Tangible assets 5 10,175 13,491
106,175 125,491

CURRENT ASSETS
Stocks 2,000 2,000
Debtors 6 24,053 20,836
Cash in hand 203 457
26,256 23,293
CREDITORS
Amounts falling due within one year 7 122,920 137,737
NET CURRENT LIABILITIES (96,664 ) (114,444 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

9,511

11,047

CREDITORS
Amounts falling due after more than one
year

8

(5,337

)

(8,540

)

PROVISIONS FOR LIABILITIES (1,933 ) (2,698 )
NET ASSETS/(LIABILITIES) 2,241 (191 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 2,240 (192 )
SHAREHOLDERS' FUNDS 2,241 (191 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

BALANCE SHEET - continued
31 MARCH 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director on 28 August 2018 and were signed by:





D T R Noble - Director


NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

1. STATUTORY INFORMATION

Noble Dental Laboratories Ltd is a private company, limited by shares, registered in Scotland. The registered
office is Caledonia House, 89 Seaward Street, Glasgow, G41 1HJ.

The financial statements are presented in Sterling (£).

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities"
of Financial reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of
Ireland" and the Companies Act 2006. There were no material departures from that standard. The financial
statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis. The validity of this is dependant on
continued support from the director. If support was to be withdrawn, adjustments may have to be made to reduce
the value of the assets to their recoverable amount and to provide for any further liabilities that may arise. The
director considers however, that it is still appropriate to prepare the financial statements on a going concern basis
despite this uncertainty.

Turnover
Turnover comprises the invoiced cost of goods and services sold during the year. The company's policy is to
recognise a sale when substantively all the risks and rewards in connection with the goods and services have been
passed to the buyer.

Goodwill
Positive purchased goodwill arising on acquisitions is capitalised, classified as an asset on the balance sheet and
amortised over its estimated useful life up to a maximum of 10 years. This length of time is presumed to be the
maximum useful life of purchased goodwill because it is difficult to make projections beyond this period.
Goodwill is reviewed for impairment at the end of the first full financial year following each acquisition and
subsequently as and when necessary if circumstances emerge that indicate that the carrying value may not be
recoverable.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 25% on reducing balance and 10% to 20% on cost

Fixed assets are included in the balance sheet at cost less accumulated depreciation and accumulated impairment
losses.

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to sell.

Financial instruments
The company only has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic
financial instruments are initially recognised at transaction value and subsequently at their settlement value.


NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2018

2. ACCOUNTING POLICIES - continued
Taxation
Taxation represents the sum of tax currently payable and deferred tax. The company's liability for current tax is
calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

The charge for taxation takes into account taxation deferred as a result of timing differences between the
treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised in
respect of all timing differences that have originated but not reversed at the balance sheet date. However,
deferred tax assets are recognised only to the extent that the director considers that it is more likely than not that
there will be suitable taxable profits from which the future reversal of the underlying timing differences can be
deducted. Deferred taxation is measured on a non-discounted basis at the tax rates that are expected to apply in
the periods in which the timing differences reverse, based on tax rates and laws enacted or substantively enacted
at the balance sheet date.

With the exception of changes arising on the initial recognition of a business combination, the tax expense is
presented either in profit or loss, other comprehensive income or statement of changes in equity depending on the
transaction that resulted in the tax expense.

Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held
under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases
are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element
of the future payments is treated as a liability.

Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2017 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2017
and 31 March 2018 160,000
AMORTISATION
At 1 April 2017 48,000
Charge for year 16,000
At 31 March 2018 64,000
NET BOOK VALUE
At 31 March 2018 96,000
At 31 March 2017 112,000

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2018

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2017 19,493
Additions 108
At 31 March 2018 19,601
DEPRECIATION
At 1 April 2017 6,002
Charge for year 3,424
At 31 March 2018 9,426
NET BOOK VALUE
At 31 March 2018 10,175
At 31 March 2017 13,491

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 April 2017
and 31 March 2018 15,428
DEPRECIATION
At 1 April 2017 3,857
Charge for year 2,893
At 31 March 2018 6,750
NET BOOK VALUE
At 31 March 2018 8,678
At 31 March 2017 11,571

These assets are held as security against hire purchase obligations.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 24,053 20,836

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2018

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Bank loans and overdrafts 9,309 10,517
Hire purchase contracts 3,202 3,202
Trade creditors 7,172 7,174
Taxation and social security 8,181 6,416
Other creditors 95,056 110,428
122,920 137,737

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2018 2017
£    £   
Hire purchase contracts 5,337 8,540

9. SECURED DEBTS

The following secured debts are included within creditors:

2018 2017
£    £   
Hire purchase contracts 8,539 11,742

Hire purchase liabilities are secured over the assets to which the contracts relate.

10. RELATED PARTY DISCLOSURES

At the year end, included in creditors, is an amount due to the director totalling £83,403 (2017 - £101,043). This
amount is interest free, unsecured and has no fixed repayment terms.